79 patents currently held
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
32 more records may belong here and await a decision; they are not counted.
The next term ends in Feb 2039. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2039
Next term end
50
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2039 · High confidence
Also notable
Ends Feb 2039 · High confidence
Also notable
Ends May 2040 · High confidence
Determining Biomarkers from Histopathology Slide Images
US 10,957,041
Cited by 93 later US patents, top 1% of utility patents granted in 2021 in our data. Protection runs to 2039.
Mobile Supplementation, Extraction, and Analysis of Health Records
US 10,395,772
Cited by 91 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2039.
Systems and Methods for Multi-Label Cancer Classification
US 11,527,323
Cited by 24 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2040.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 20, 2026
- 5 fees due Feb 1 to 28, 2027 · next Feb 1
- 1 fee due Jun 19, 2027The maintenance fee for Predicting Likelihood and Site of Metastasis from Patient Records (US 11,848,107) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
- 2 fees due Jul 9 to 16, 2027 · next Jul 9
- 1 fee due Sep 19, 2027The maintenance fee for Determining Biomarkers from Histopathology Slide Images (US 11,935,152) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
Recent changes
- 8 of the patents on this record were granted since Aug 17, 2026
What they patent
The 5 largest of its 50 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Generalizable and Interpretable Deep Learning Framework for Predicting MSI from Histopathology Slide Images | 12 in force | to Jan 2042 |
| Mobile Supplementation, Extraction, and Analysis of Health Records | 5 in force | to Jan 2040 |
| Predicting Likelihood and Site of Metastasis from Patient Records | 3 in force | to Sep 2041 |
| Data-Based Mental Disorder Research and Treatment Systems and Methods | 3 in force | to Jun 2040 |
| Systems and Methods for Next Generation Sequencing Uniform Probe Design | 2 in force | to Oct 2043 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,395,772 | Mobile Supplementation, Extraction, and Analysis of Health Records In force · High confidence | In force | High confidence | |
| US 10,902,952 | Mobile Supplementation, Extraction, and Analysis of Health Records In force · Medium confidence | In force | Medium confidence | |
| US 11,532,397 | Mobile Supplementation, Extraction, and Analysis of Health Records In force · Medium confidence | In force | Medium confidence | |
| US 11,651,442 | Mobile Supplementation, Extraction, and Analysis of Health Records In force · Medium confidence | In force | Medium confidence | |
| US D1,019,606 | Speaker In force · High confidence | In force | High confidence | |
| US 10,957,041 | Determining Biomarkers from Histopathology Slide Images In force · High confidence | In force | High confidence | |
| US 11,263,748 | Determining Biomarkers from Histopathology Slide Images In force · High confidence | In force | High confidence | |
| US 11,348,239 | Predicting Total Nucleic Acid Yield and Dissection Boundaries for Histology Slides In force · High confidence | In force | High confidence | |
| US 11,348,240 | Predicting Total Nucleic Acid Yield and Dissection Boundaries for Histology Slides In force · High confidence | In force | High confidence | |
| US 11,348,661 | Predicting Total Nucleic Acid Yield and Dissection Boundaries for Histology Slides In force · High confidence | In force | High confidence |
Also on record, not counted in the 79: 2 patents in force now held by others · 99 applications pending · 15 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.